Royalty Pharma has no current AI or cloud hiring signals in our index. Revenue growth: +5% YoY (annual revenue: $2.3B) — classified as ➡ Stable per SEC 10-K filing. Publicly traded as RPRX. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.
📊 Company Overview
📈 Financial Signals (SEC 10-K)
| Annual Revenue | $2.3B |
|---|---|
| Revenue Growth (YoY) | +5.1% |
| Growth Tier | ➡ Stable |
Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →
🎯 Outreach Strategy
Discovery questions based on Royalty Pharma’s signals — paste into your AI or CRM
“With +5% revenue growth, cloud ROI conversations tend to shift to optimization. Where are you finding the most efficiency gains?”
☁️ Cloud Infrastructure
| Workspace | 🔒 Subscribers only |
|---|---|
| CDN | 🔒 Subscribers only |
Detected via DNS records and HTTP response headers as of 2026-07-20.
💰 Estimated Cloud Spend
🛠 Tech Stack & Marketing
| Ad Platforms | 🔒 Subscribers only |
|---|---|
| Analytics & CRM | 🔒 Subscribers only |
| CMS / Platform | WordPress |
| Frontend Stack | 🔒 Subscribers only |
Detected from Royalty Pharma's public homepage as of 2026-07-20.
🔍 Compare with Similar Companies
Same sector (Professional Services), similar size
Data detected 2026-07-20 · Methodology · Suggest a correction